Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
Wagner S, Kayser S, Engelmann J, Schlicht KF, Dreimüller N, Tüscher O, Müller-Dahlhaus F, Braus DF, Tadić A, Neyazi A, Frieling H, Lieb K. Wagner S, et al. Among authors: schlicht kf. World J Biol Psychiatry. 2019 Sep;20(7):519-530. doi: 10.1080/15622975.2018.1425478. Epub 2018 Feb 2. World J Biol Psychiatry. 2019. PMID: 29334322 Clinical Trial.
Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.
Engelmann J, Wagner S, Wollschläger D, Kaaden S, Schlicht KF, Dreimüller N, Braus DF, Müller MB, Tüscher O, Frieling H, Tadić A, Lieb K. Engelmann J, et al. Among authors: schlicht kf. Eur Arch Psychiatry Clin Neurosci. 2020 Mar;270(2):183-193. doi: 10.1007/s00406-019-01006-z. Epub 2019 Mar 30. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 30929060
The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.
Tadić A, Wagner S, Schlicht KF, Peetz D, Borysenko L, Dreimüller N, Hiemke C, Lieb K. Tadić A, et al. Among authors: schlicht kf. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):415-20. doi: 10.1016/j.pnpbp.2010.08.011. Epub 2010 Aug 20. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20732374 Clinical Trial.
Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.
Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, Kaiser AK, Kronfeld K, Schlicht KF, Tüscher O, Wagner S, Hiemke C, Lieb K. Tadić A, et al. Among authors: schlicht kf. Eur Neuropsychopharmacol. 2016 Apr;26(4):705-16. doi: 10.1016/j.euroneuro.2016.02.003. Epub 2016 Feb 9. Eur Neuropsychopharmacol. 2016. PMID: 26899588 Clinical Trial.
WITHDRAWN: Association analysis between the early change of serum brain-derived neurotrophic factor (sBDNF) and final change of depression severity during antidepressant treatment: A pilot study.
Tadić A, Wagner S, Schlicht KF, Peetz D, Borysenko L, Krannich D, Bernius A, Hiemke C, Lieb K. Tadić A, et al. Among authors: schlicht kf. Eur Neuropsychopharmacol. 2010 Dec 13. doi: 10.1016/j.euroneuro.2010.08.007. Online ahead of print. Eur Neuropsychopharmacol. 2010. PMID: 20888738
Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
Tadić A, Gorbulev S, Dahmen N, Hiemke C, Braus DF, Röschke J, van Calker D, Wachtlin D, Kronfeld K, Gorbauch T, Seibert-Grafe M, Lieb K; EMC Study Group. Tadić A, et al. Trials. 2010 Feb 26;11:21. doi: 10.1186/1745-6215-11-21. Trials. 2010. PMID: 20187947 Free PMC article. Clinical Trial.
12 results